ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 126 filers reported holding ANAPTYSBIO INC in Q2 2018. The put-call ratio across all filers is 2.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $920,000 | -53.6% | 56,602 | -0.0% | 0.01% | -60.0% |
Q3 2019 | $1,981,000 | -38.0% | 56,604 | +0.0% | 0.02% | -37.5% |
Q2 2019 | $3,193,000 | -61.2% | 56,602 | -49.8% | 0.02% | -64.7% |
Q1 2019 | $8,233,000 | +5.2% | 112,700 | -8.1% | 0.07% | -11.7% |
Q4 2018 | $7,827,000 | +1917.3% | 122,700 | +3189.5% | 0.08% | +1440.0% |
Q1 2018 | $388,000 | – | 3,730 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |